CN1717488A - 包含至少两个牛痘ati启动子的重组痘病毒 - Google Patents

包含至少两个牛痘ati启动子的重组痘病毒 Download PDF

Info

Publication number: CN1717488A
Authority: CN; China
Prior art keywords: virus; poxvirus; mva; recombinant; sequence
Prior art date: 2002-11-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CNA2003801040985A

Other languages

English (en)

Chinese (zh)

Inventor

桑贾·莱勒

保罗·豪利

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bavarian Nordic AS

Original Assignee

Bavarian Nordic AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-25

Filing date

2003-11-12

Publication date

2006-01-04

2003-11-12 Application filed by Bavarian Nordic AS filed Critical Bavarian Nordic AS

2006-01-04 Publication of CN1717488A publication Critical patent/CN1717488A/zh

Status Pending legal-status Critical Current

Links

Images

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/863—Poxviral vectors, e.g. entomopoxvirus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Plant Pathology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Tropical Medicine & Parasitology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Mycology (AREA)
Epidemiology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CNA2003801040985A 2002-11-25 2003-11-12 包含至少两个牛痘ati启动子的重组痘病毒 Pending CN1717488A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200201814		2002-11-25
DKPA200201814		2002-11-25

Publications (1)

Publication Number	Publication Date
CN1717488A true CN1717488A (zh)	2006-01-04

Family

ID=32337938

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CNA2003801040985A Pending CN1717488A (zh)	2002-11-25	2003-11-12	包含至少两个牛痘ati启动子的重组痘病毒

Country Status (21)

Country	Link
US (1)	US7300658B2 (fr)
EP (1)	EP1567653B1 (fr)
JP (1)	JP2006515170A (fr)
KR (1)	KR20050083839A (fr)
CN (1)	CN1717488A (fr)
AT (1)	ATE365220T1 (fr)
AU (1)	AU2003293675B2 (fr)
CA (1)	CA2501168A1 (fr)
CY (1)	CY1106883T1 (fr)
DE (1)	DE60314541T2 (fr)
DK (1)	DK1567653T3 (fr)
EA (1)	EA012723B1 (fr)
ES (1)	ES2288634T3 (fr)
IL (1)	IL167844A (fr)
MX (1)	MXPA05005549A (fr)
NO (1)	NO20053125D0 (fr)
NZ (1)	NZ540156A (fr)
PL (1)	PL375740A1 (fr)
PT (1)	PT1567653E (fr)
UA (1)	UA85379C2 (fr)
WO (1)	WO2004048582A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102341120A (zh) *	2009-03-13	2012-02-01	巴法里安诺迪克有限公司	结合重复免疫的优化早晚期启动子辅助对复制缺陷型重组病毒疫苗抗原的细胞毒t细胞应答

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU230198B1 (hu) *	2000-11-23	2015-10-28	Bavarian Nordic A/S	Módosított Vacciniavírus Ankara-variáns
US7501127B2 (en)	2002-05-16	2009-03-10	Bavarian Nordic A/S	Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara
UA82479C2 (uk) *	2002-05-16	2008-04-25	Бавариан Нордика А/С	Міжгенні регіони як сайти вставки в геном модифікованого вірусу коров'ячої віспи ankara (mva)
EP2415783B1 (fr)	2006-10-16	2016-12-14	Genelux Corporation	Souches de virus de vaccin modifiées pour une utilisation pour le diagnostic et procédé thérapeutique
US20110052627A1 (en) *	2008-06-20	2011-03-03	Paul Chaplin	Recombinant modified vaccinia virus measles vaccine
EP2352834B1 (fr)	2008-11-21	2016-12-21	Bavarian Nordic A/S	Virus comprenant séquences d' acides nucléiques codant les multiples homologues
WO2013115884A2 (fr) *	2011-11-15	2013-08-08	Trustees Of Boston University	Inhibiteurs de virus, de type pyridopyrimidinone
US11701418B2 (en)	2015-01-12	2023-07-18	Geovax, Inc.	Replication-deficient modified vaccinia Ankara (MVA) expressing Ebola virus glycoprotein (GP) and matrix protein (VP40)
KR20160140075A (ko)	2015-05-29	2016-12-07	코오롱생명과학 주식회사	폭스바이러스 유래 프로모터 및 이를 포함하는 벡터
FR3042121A1 (fr)	2015-10-08	2017-04-14	Jean-Marc Limacher	Composition anti-tumorale
FR3044016A1 (fr) *	2015-11-24	2017-05-26	Glaxosmithkline Ip Dev Ltd	Lignees cellulaires stables pour la production retrovirale
KR102067352B1 (ko) *	2015-11-24	2020-01-16	글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드	레트로바이러스 생산을 위한 일시적인 형질감염 방법
CN109071592B (zh)	2016-01-08	2022-07-19	吉奥瓦科斯公司	用于产生对肿瘤相关抗原的免疫应答的组合物和方法
US20190030157A1 (en)	2016-02-03	2019-01-31	Geovax Inc.	Compositions and Methods for Generating an Immune Response to a Flavivirus
KR20250067190A (ko) *	2016-08-09	2025-05-14	시티 오브 호프	키메라 폭스바이러스 조성물 및 이의 용도
US11311612B2 (en)	2017-09-19	2022-04-26	Geovax, Inc.	Compositions and methods for generating an immune response to treat or prevent malaria
CA3167052A1 (fr)	2020-02-14	2021-08-19	Mary Jo Hauser	Vaccins et leurs utilisations pour induire une reponse immunitaire contre sras-cov2
FR3160186A1 (fr)	2024-03-13	2025-09-19	Odimma Therapeutics	Vecteur non-viral pour transcription augmentee
FR3171450A1 (fr)	2025-01-17	2026-07-24	Odimma Therapeutics	Virus enveloppé pour la transfection d’acides nucléiques exogènes.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5443964A (en) *	1987-08-10	1995-08-22	Duke University	Poxvirus insertion/expression vector
US5759841A (en) *	1990-11-20	1998-06-02	Virogenetics Corporation	Immunological composition of measles virus utilizing recombinant poxvirus
UA68327C2 (en) *	1995-07-04	2004-08-16	Gsf Forschungszentrum Fur Unwe	A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
ID19548A (id) *	1996-09-24	1998-07-23	Bavarian Nordic Res Inst As	Virus mva rekombinan yang mengekspresikan antigen-antigen virus demam dan penggunaan daripadanya dalam vaksin-vaksin
WO2000073476A1 (fr) *	1999-05-28	2000-12-07	Gsf Forschungszentrum Für Umwelt Und Gesundheit Gmbh	Vecteur d'integration de sequences heterologues dans des genomes de poxvirus
EP1326990B1 (fr) *	2000-08-29	2007-09-19	Wyeth Holdings Corporation	Encapsulation de particules de replicon de virus d'arn a chaine positive

2003
- 2003-11-12 AT AT03789029T patent/ATE365220T1/de active
- 2003-11-12 ES ES03789029T patent/ES2288634T3/es not_active Expired - Lifetime
- 2003-11-12 CA CA002501168A patent/CA2501168A1/fr not_active Abandoned
- 2003-11-12 UA UAA200506292A patent/UA85379C2/ru unknown
- 2003-11-12 DE DE60314541T patent/DE60314541T2/de not_active Expired - Lifetime
- 2003-11-12 EA EA200500879A patent/EA012723B1/ru not_active IP Right Cessation
- 2003-11-12 AU AU2003293675A patent/AU2003293675B2/en not_active Ceased
- 2003-11-12 PL PL03375740A patent/PL375740A1/xx not_active Application Discontinuation
- 2003-11-12 DK DK03789029T patent/DK1567653T3/da active
- 2003-11-12 WO PCT/EP2003/012610 patent/WO2004048582A2/fr not_active Ceased
- 2003-11-12 JP JP2004554335A patent/JP2006515170A/ja active Pending
- 2003-11-12 EP EP03789029A patent/EP1567653B1/fr not_active Expired - Lifetime
- 2003-11-12 MX MXPA05005549A patent/MXPA05005549A/es active IP Right Grant
- 2003-11-12 NZ NZ540156A patent/NZ540156A/en not_active IP Right Cessation
- 2003-11-12 KR KR1020057007295A patent/KR20050083839A/ko not_active Abandoned
- 2003-11-12 US US10/535,371 patent/US7300658B2/en not_active Expired - Fee Related
- 2003-11-12 CN CNA2003801040985A patent/CN1717488A/zh active Pending
- 2003-11-12 PT PT03789029T patent/PT1567653E/pt unknown
2005
- 2005-04-04 IL IL167844A patent/IL167844A/en not_active IP Right Cessation
- 2005-06-24 NO NO20053125A patent/NO20053125D0/no not_active Application Discontinuation
2007
- 2007-09-20 CY CY20071101220T patent/CY1106883T1/el unknown

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102341120A (zh) *	2009-03-13	2012-02-01	巴法里安诺迪克有限公司	结合重复免疫的优化早晚期启动子辅助对复制缺陷型重组病毒疫苗抗原的细胞毒t细胞应答
CN102341120B (zh) *	2009-03-13	2016-05-18	巴法里安诺迪克有限公司	结合重复免疫的优化早晚期启动子辅助对复制缺陷型重组病毒疫苗抗原的细胞毒t细胞应答

Also Published As

Publication number	Publication date
IL167844A (en)	2011-03-31
EA012723B1 (ru)	2009-12-30
EA200500879A1 (ru)	2005-10-27
ES2288634T3 (es)	2008-01-16
PL375740A1 (en)	2005-12-12
CA2501168A1 (fr)	2004-06-10
CY1106883T1 (el)	2012-09-26
DE60314541T2 (de)	2008-02-28
NO20053125L (no)	2005-06-24
NZ540156A (en)	2006-11-30
WO2004048582A2 (fr)	2004-06-10
US20060153874A1 (en)	2006-07-13
UA85379C2 (ru)	2009-01-26
NO20053125D0 (no)	2005-06-24
PT1567653E (pt)	2007-10-01
US7300658B2 (en)	2007-11-27
MXPA05005549A (es)	2005-08-16
AU2003293675A1 (en)	2004-06-18
KR20050083839A (ko)	2005-08-26
EP1567653A2 (fr)	2005-08-31
DK1567653T3 (da)	2007-10-15
JP2006515170A (ja)	2006-05-25
AU2003293675B2 (en)	2009-04-23
DE60314541D1 (de)	2007-08-02
EP1567653B1 (fr)	2007-06-20
ATE365220T1 (de)	2007-07-15
WO2004048582A3 (fr)	2004-08-12

Legal Events

Date	Code	Title	Description
2006-01-04	C06	Publication
2006-01-04	PB01	Publication
2006-03-01	C10	Entry into substantive examination
2006-03-01	SE01	Entry into force of request for substantive examination
2006-05-26	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1081997 Country of ref document: HK
2012-06-22	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1081997 Country of ref document: HK
2012-07-11	C02	Deemed withdrawal of patent application after publication (patent law 2001)
2012-07-11	WD01	Invention patent application deemed withdrawn after publication	Open date: 20060104

Publication	Publication Date	Title
CN1653183A (zh)	2005-08-10	表达插入痘病毒基因组中的同源基因的重组痘病毒
CN1055501C (zh)	2000-08-16	重组禽痘病毒,培养被上述病毒感染的细胞以及从上述病毒得到的家禽疫苗
CN1201013C (zh)	2005-05-11	用于减少同源重组现象的腺病毒载体及方法
CN1114355A (zh)	1996-01-03	Dna扩增
CN1602316A (zh)	2005-03-30	黄病毒ns1亚单位疫苗
CN1898390A (zh)	2007-01-17	用于在改良安卡拉痘苗病毒中进行表达的启动子
CN1869243A (zh)	2006-11-29	基于重组猪腺病毒的病毒载体和病毒疫苗
CN1437613A (zh)	2003-08-20	修饰的麻疹病毒v蛋白
CN1289663C (zh)	2006-12-13	从感染细胞中回收和纯化痘病毒的方法
CN100335131C (zh)	2007-09-05	重组火鸡疱疹病毒及其应用
CN1109260A (zh)	1995-09-27	转导醛脱氢酶-1基因的反转录病毒载体及其应用
CN1181202C (zh)	2004-12-22	苏云金芽孢杆菌cryl基因、基因组合及表达载体
CN1569899A (zh)	2005-01-26	一种神经坏死病毒重组蛋白疫苗及其编码序列和用途
CN1570115A (zh)	2005-01-26	优化的sars冠状病毒刺突蛋白基因
CN101067140A (zh)	2007-11-07	鸡痘病毒表达载体p12－18及其构建方法
CN1183250C (zh)	2005-01-05	高效表达肿瘤血管生成抑制因子的肿瘤细胞内特异性增殖的病毒及其构建方法
CN100339479C (zh)	2007-09-26	参与油菜素类固醇合成的基因
HK1081997A (en)	2006-05-26	Recombinant poxvirus comprising at least two cowpox ati promoters
HK1096707A (en)	2007-06-08	Promoters for expression in modified vaccinia virus ankara
CN1163604C (zh)	2004-08-25	减毒水痘病毒冈株的基因62和利用基因62的减毒水痘活疫苗用病毒株的鉴定方法
CN1769433A (zh)	2006-05-10	重组水疱性口炎病毒及其应用
CN1532282A (zh)	2004-09-29	一种新型抗肠球菌多肽及其制备方法
CN101054590A (zh)	2007-10-17	天山雪莲sikSACPD基因在培育抗寒植物中的应用
CN100350049C (zh)	2007-11-21	乳酸乳球菌的食品级载体
CN1273587C (zh)	2006-09-06	疱疹病毒胸苷激酶突变体及其应用